These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
154 related items for PubMed ID: 15867173
1. Association of prolonged QRS duration with death in a clinical trial of pacemaker therapy for sinus node dysfunction. Sweeney MO, Hellkamp AS, Lee KL, Lamas GA, Mode Selection Trial (MOST) Investigators. Circulation; 2005 May 17; 111(19):2418-23. PubMed ID: 15867173 [Abstract] [Full Text] [Related]
2. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Sweeney MO, Hellkamp AS, Ellenbogen KA, Greenspon AJ, Freedman RA, Lee KL, Lamas GA, MOde Selection Trial Investigators. Circulation; 2003 Jun 17; 107(23):2932-7. PubMed ID: 12782566 [Abstract] [Full Text] [Related]
9. Prolonged paced QRS duration as a predictor for congestive heart failure in patients with right ventricular apical pacing. Miyoshi F, Kobayashi Y, Itou H, Onuki T, Matsuyama T, Watanabe N, Liu C, Kawamura M, Asano T, Miyata A, Nakagawa H, Tanno K, Baba T, Katagiri T. Pacing Clin Electrophysiol; 2005 Nov 13; 28(11):1182-8. PubMed ID: 16359284 [Abstract] [Full Text] [Related]
11. Atrial vs. dual-chamber cardiac pacing in sinus node disease: a register-based cohort study. Fored CM, Granath F, Gadler F, Blomqvist P, Rynder J, Linde C, Ekbom A, Rosenqvist M. Europace; 2008 Jul 13; 10(7):825-31. PubMed ID: 18467299 [Abstract] [Full Text] [Related]
12. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study. De Marco T, Wolfel E, Feldman AM, Lowes B, Higginbotham MB, Ghali JK, Wagoner L, Kirlin PC, Kennett JD, Goel S, Saxon LA, Boehmer JP, Mann D, Galle E, Ecklund F, Yong P, Bristow MR. J Card Fail; 2008 Feb 13; 14(1):9-18. PubMed ID: 18226768 [Abstract] [Full Text] [Related]
13. Prognostic value of electrocardiographic measurements before and after cardiac resynchronization device implantation in patients with heart failure due to ischemic or nonischemic cardiomyopathy. Iler MA, Hu T, Ayyagari S, Callahan TD, Civello KC, Thal SG, Wilkoff BL, Chung MK. Am J Cardiol; 2008 Feb 01; 101(3):359-63. PubMed ID: 18237600 [Abstract] [Full Text] [Related]
14. Heart failure hospitalization is more common in pacemaker patients with sinus node dysfunction and a prolonged paced QRS duration. Shukla HH, Hellkamp AS, James EA, Flaker GC, Lee KL, Sweeney MO, Lamas GA, Mode Selection Trial (MOST) Investigators. Heart Rhythm; 2005 Mar 01; 2(3):245-51. PubMed ID: 15851312 [Abstract] [Full Text] [Related]
15. QRS duration in high-resolution methods and standard ECG in risk assessment after first and recurrent myocardial infarctions. Korhonen P, Husa T, Tierala I, Väänänen H, Mäkijärvi M, Katila T, Toivonen L. Pacing Clin Electrophysiol; 2006 Aug 01; 29(8):830-6. PubMed ID: 16922998 [Abstract] [Full Text] [Related]
16. Prognostic importance of change in QRS duration over time associated with left ventricular dysfunction in patients with congestive heart failure: the DIAMOND study. Fosbøl EL, Seibaek M, Brendorp B, Torp-Pedersen C, Køber L, Danish Investigations and Arrhythmia on Dofetilide (Diamond) Study Group. J Card Fail; 2008 Dec 01; 14(10):850-5. PubMed ID: 19041049 [Abstract] [Full Text] [Related]